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Abstract 
Background and Aim: Although sporadic non-ampullary duodenal adenoma is 
speculated to be precancerous lesion, the relationship between adenoma and carcinoma 
remains unclear due to their rarity. Previous studies on sporadic non-ampullary 
duodenal epithelial neoplasm (SNADEN) have mainly targeted superficial tumors, like 
adenoma and early carcinoma. The clinicopathological features, including those of 
advanced carcinoma, remain poorly investigated. We assessed the clinicopathological 
features of SNADEN, including advanced carcinoma, focusing on tumor location. 
Methods: We retrospectively collected the data of 410 patients who had been clinically 
and pathologically diagnosed with SNADEN at 11 institutions in Japan between June 
2002 and March 2014.  
Results: The SNADEN was mucosal neoplasia and invasive carcinoma in 321 (78.3%) 
and 89 (21.7) patients, respectively. The proportion of invasive carcinomas in 
SNADEN was significantly higher on the oral side of the papilla of Vater (oral-Vater) 
than on the anal side (anal-Vater) (27.9% vs. 14.4%, P < 0.001). Undifferentiated-type 
carcinoma was significantly more frequent with oral-Vater than anal-Vater (38.7% vs. 
14.8%, P = 0.026). The recurrence rate of surgically R0 resected locally advanced 
carcinomas was significantly higher with oral-Vater than anal-Vater (46.4% vs. 8.3%, 
P = 0.021). Furthermore, the relapse-free survival with oral-Vater was significantly 
shorter than with anal-Vater (HR: 2.35; 95% confidence interval: 1.09–5.50; P = 
0.028). 
Conclusions: The clinicopathological features of SNADEN on oral-Vater were 
different from those on anal-Vater. SNADEN on oral-Vater was more likely to be 
invasive carcinomas and might behave more aggressively due to biologically higher 
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malignancy than that on anal-Vater. 
 
Keywords Sporadic non-ampullary duodenal epithelial neoplasm (SNADEN); tumor 
location; clinicopathological differences 
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Introduction 
Approximately 60% of duodenal adenomas develop in patients with familial 
adenomatous polyposis (FAP), while the remaining 40% are sporadic 1. Sporadic 
non-ampullary duodenal adenoma (SNDA) is uncommon 2, 3, and little is known about 
its natural history. SNDA is thought to be a precancerous lesion, and the model of the 
adenoma-carcinoma sequence is predicted to involve the small intestine, including the 
duodenum and colorectum 4-6. However, not all SNDA lead to carcinoma 7, and some 
previous reports have suggested that there was not only the adenoma-carcinoma 
sequence but also the de novo pathway in the carcinogenesis of duodenal carcinoma 7-10.  
There have been several reports on the clinicopathological differences in superficial 
non-ampullary duodenal epithelial neoplasm according to the tumor location, 
particularly between the oral and anal side of the papilla of Vater 8, 9, 11. Gastric-type 
tumors have been found to be more frequently located on the oral side of the papilla of 
Vater (oral-Vater) than on the anal side of the papilla of Vater (anal-Vater), and they 
are predicted to have a higher malignancy than intestinal-type tumors. In contrast, 
many of the tumors on anal-Vater are intestinal-type which are predicted to have lower 
malignant potential than gastric-type 8, 9. However, since all of the previous studies 
examined data of only superficial tumors like adenoma and early carcinoma, the 
clinicopathological characteristics of sporadic non-ampullary duodenal epithelial 
neoplasm (SNADEN), including advanced carcinoma, are unclear. 
As SNADEN is rare 12, 13, most previous studies were conducted at single tertiary-care 
centers. Furthermore, there has been no study including carcinoma in advanced stages. 
Data of these studies were potentially limited by selection bias and may not accurately 
reflect the true SNADEN status. In this study, we conducted a multicenter observational 
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study to elucidate the relationship between adenomas and carcinomas, including early 
and advanced stages, and the clinicopathological features of SNADEN according to the 
tumor location. 
 
Methods 
Patients 
This was a multicenter, retrospective, observational study included a total of 410 
patients at the following 11 hospitals from June 2002 and March 2014: Okayama 
University Hospital, Kurashiki Central Hospital, Okayama Saiseikai General Hospital, 
Hiroshima City Hiroshima Citizens Hospital, Japanese Red Cross Okayama Hospital, 
Kagawa Prefectural Hospital, Mitoyo General Hospital, Japanese Red Cross Society 
Himeji Hospital, Tsuyama Chuo Hospital, Sumitomo Besshi Hospital, and Akaiwa 
Medical Association Hospital. Patient data were collected after approval by the 
institutional review boards of each hospital. The ethics committee of each hospital 
approved this retrospective study and informed consent was acquired by the opt-out 
method. 
 
Data collection 
Data of patients with duodenal tumors with a histological diagnosis of adenoma or 
carcinoma were included in this study. The exclusion criteria were as follows: (1) tumor 
located on the ampulla of Vater, (2) familial adenomatous polyposis, (3) suspected 
invasive tumor of the pancreas, and (4) duodenal metastasis from the cancer of other 
organs. Patients’ medical records were reviewed, and the following clinicopathological 
parameters were collected: gender, age, site of primary tumor, size of primary tumor, 
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morphology of primary tumor, histological type, symptoms at diagnosis, Union for 
International Cancer Control (8th ed.) cancer stage based on the tumor, nodes, 
metastasis (TNM) classification, treatment strategy, and patient prognosis. If a patient 
had multiple SNADENs, we evaluated the lesion that was the largest and most 
advanced. We investigated the clinicopathological features of SNADEN and compared 
the features according to the tumor location. 
 
Histological examination 
For histological analysis, tissue specimens were routinely fixed with formalin and 
completely embedded in paraffin. Tissue blocks were thinly sectioned, routinely 
processed, and stained with hematoxylin and eosin (H&E). All SNADENs were 
histologically graded based on the revised Vienna classification (VCL) 14. Qualified 
pathologists at each hospital assessed histological grade. We defined VCL category 3 
(low-grade dysplasia), 4.1 (high-grade dysplasia), 4.2 (carcinoma in situ), 4.3 
(suspicious for invasive carcinoma), or 4.4 (intramucosal carcinoma) as mucosal 
neoplasia, and VCL category 5 (submucosal invasion by carinoma) as invasive 
carcinoma. We classified VCL category 3 as low-grade neoplasia, and 4 as high-grade 
neoplasia. Invasive carcinoma was subdivided into differentiated-type or 
undifferentiated-type depending on histopathological grading. 
 
Statistical analysis 
 All continuous variables are reported as the median (range), and all categorical 
variables are summarized as frequencies (percentages). Wilcoxon’s rank-sum test was 
used to compare the continuous variables. Pearson's chi-square test or Fisher’s exact test 
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was used to compare the categorical variables. The overall survival (OS) and 
relapse-free survival (RFS) were estimated by the Kaplan–Meier method, and the 
differences were evaluated using the log-rank test. A Cox proportional hazard model 
was used to assess the OS and RFS by tumor location. All tests were two-sided, and a 
P-value under 0.05 was considered statistically significant. Statistical analyses were 
performed using the JMP 13 software program (SAS Institute Inc., Cary, NC, USA). 
 
Results 
Patient characteristics 
Four-hundred and ten patients from the 11 institutions were included in this study, and 
their characteristics are summarized in Table 1. Median age of all patients was 67 years 
(range, 29–89), and 267 of the 410 (65.1%) patients were men while 143 (34.9%) were 
women. Of the 410 patients with SNADEN examined, 321 (78.3%) were diagnosed 
with mucosal neoplasia, and 89 (21.7%) were diagnosed with invasive carcinoma based 
on a histological examination of endoscopic biopsy or resected specimens. While the 
number of both mucosal neoplasias and invasive carcinomas were larger in men. Large 
tumor size and symptom were significantly correlated with invasive carcinoma (P < 
0.001 and P < 0.001, respectively). Although advanced age was significantly correlated 
with invasive carcinoma, the difference was slight (median age, 67 vs. 68 years, P = 
0.0022). 
 
Comparison of the proportion of SNADEN between oral-Vater and anal-Vater 
A total of 222 (54.1%) SNADENs were located on oral-Vater, while 188 (45.9%) were 
located on anal-Vater. Figure 1 shows the proportion of SNADEN according to the 
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tumor location. The proportion of invasive carcinomas on oral-Vater was significantly 
higher than anal-Vater (27.9% vs. 14.4%, P < 0.001). Similarly, the proportion of both 
stage I invasive carcinomas and stage II-IV invasive carcinomas were significantly 
higher on oral-Vater than anal-Vater (3.6% vs. 0.5%, P = 0.034, and 24.3% vs. 13.8%, P 
= 0.0075, respectively). 
 
Comparison between oral-Vater and anal-Vater in mucosal neoplasias and 
invasive carcinomas 
The 321 mucosal neoplasias were divided into 160 lesions on oral-Vater and 161 lesions 
on anal-Vater (Table 2). There were no significant differences in sex, age, or tumor size 
between the two groups. Regarding histological type, the proportion of high-grade 
neoplasia was significantly higher on oral-Vater than on anal-Vater (28.7% vs. 19.3%, P 
= 0.046). Protruded-type was significantly more frequent on oral-Vater, while 
superficial-type was significantly more frequent on anal-Vater (P < 0.001). 
The 89 invasive carcinomas were divided into 62 lesions on oral-Vater and 27 on 
anal-Vater. The results of univariate analysis between the two groups among invasive 
carcinomas are summarized in Table 3. There were no significant differences in sex, 
age, tumor size, symptom, or TNM stage between the two groups. With regard to 
histological type, the proportion of undifferentiated-type carcinomas was significantly 
higher on oral-Vater than on anal-Vater (38.7% vs. 14.8%, P = 0.026). The 28 
undifferentiated-type carcinomas were all advanced carcinomas. 
 
The prognosis of advanced carcinomas according to tumor location 
Regarding stage II-IV invasive carcinomas, 55 lesions were located on oral-Vater, 
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while 24 were located on anal-Vater. There was no significant difference in stage or OS 
between the two groups (median OS: 16.0 vs. 20.6 months, P = 0.88). 
We defined carcinomas invading the muscularis propria (T2) and deeper (T3 and T4) 
without distant metastasis as locally advanced carcinomas. The 40 patients with locally 
advanced carcinomas received surgical resection with no residual tumor (R0). The 
surgically R0 resected locally advanced carcinomas were divided into 28 lesions on 
oral-Vater (oral-Vater group) and 12 on anal-Vater (anal-Vater group). Table 4 shows a 
comparison of the characteristics of patients with surgically R0 resected locally 
advanced carcinomas according to the tumor location. There was no significant 
difference in stage between the two groups. Postoperative recurrence occurred 
significantly more often on oral-Vater than on anal-Vater (46.4% vs. 8.3%, P = 0.021). 
Kaplan–Meier curves of RFS by tumor location are shown in Figure 2. The median 
RFS for the oral-Vater and anal-Vater groups was 17.1 and 63.6 months, respectively. 
The RFS of the oral-Vater group was significantly shorter than that of the anal-Vater 
group (HR: 2.35; 95% confidence interval: 1.09–5.50; P = 0.028). Similarly, the 
median OS of 19.6 months in the oral-Vater group was shorter than that of 63.6 months 
in the anal-Vater group, but the difference was not statistically significant (P = 0.11).  
 
Discussion 
This study is the first to focus on the relationship between mucosal neoplasias and 
invasive carcinomas, including early and advanced stages, and the clinicopathological 
features according to the tumor location, as described in the introduction. From this 
study, the incidence of invasive carcinomas, including early and advanced stage, was 
found to be correlated with the tumor location, and the clinicopathological features of 
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advanced carcinoma were found to differ between oral-Vater and anal-Vater. The 
incidence of invasive carcinomas on oral-Vater was higher, and the clinical behavior of 
advanced carcinomas on oral-Vater was worse, compared with that on anal-Vater. 
The clinicopathological features of SNADEN were different depending on the tumor 
location in the current study. The proportion of invasive carcinomas on oral-Vater was 
significantly higher than on anal-Vater, regardless of the stage. As a result, it turned out 
that SNADEN on oral-Vater seemed to have worse malignant potential than that on 
anal-Vater. The proportion of both high-grade neoplasias and undifferentiated-type 
carcinomas were also significantly higher on oral-Vater than on anal-Vater. It is known 
that the mucosa in the proximal duodenum can potentially undergo gastric metaplasia 
in the duodenum (GMD) caused by exposure to gastric acid 15. The GMD is thought to 
be a potentially precancerous state, leading to de novo carcinoma on oral-Vater 16. This 
may be one of the reasons for which oral-Vater SNADEN tends to be diagnosed as 
invasive carcinoma and undifferentiated-type carcinoma. 
We investigated the prognosis and postoperative recurrence in order to verify the 
difference in the grade of malignancy according to the tumor location. Regarding stage 
II-IV invasive carcinomas, there were no significant differences in OS between 
oral-Vater and anal-Vater. In contrast, regarding surgically R0 resected locally 
advanced carcinomas, postoperative recurrence occurred significantly more often on 
oral-Vater than on anal-Vater. Furthermore, the median RFS of 17.1 months in the 
oral-Vater group was significantly shorter than that of 63.6 months in the anal-Vater 
group. The matters of undifferentiated-type mentioned above, postoperative recurrence, 
and RFS suggested that advanced carcinomas on oral-Vater aggressively behave as 
biologically higher malignancy. Previous studies have reported that there were the 
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histopathological differences of superficial non-ampullary duodenal epithelial 
neoplasm between oral-Vater and anal-Vater 8, 9, 11. Our date clarified the differences in 
clinical behavior of invasive carcinomas, including early and advanced stages, 
according to the tumor location. 
This study has several limitations. First, this was a retrospective study. Future 
prospective research should be conducted to further clarify the association between 
malignancy of SNADEN and tumor location. However, our clinical data revealed 
differences in the clinicopathological features of SNADEN, including advanced 
carcinoma, between oral-Vater and anal-Vater. Therefore, the results of this study 
might help future research related to the pathogenesis of SNADEN according to the 
tumor location. Second, because some patients with locally advanced carcinomas 
underwent partial resection without lymphadenectomy, we excluded these cases from 
the analysis of surgically R0 resected locally advanced carcinoma. This might have 
resulted in some degree of selection bias in this analysis. However, the cases of partial 
resection without lymphadenectomy in both groups was small and almost same, and 
we believe that the substantial difference in the median RFS was extremely 
meaningful. 
In conclusion, the clinicopathological features of SNADEN, including advanced 
carcinoma, differed between oral-Vater and anal-Vater as well as superficial 
non-ampullary duodenal epithelial neoplasm. SNADEN on oral-Vater might have 
significantly higher malignant potential than on anal-Vater. 
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